江蘇吳中(600200.SH)上半年經營數據醫藥業務增17.47%至7.79億元
格隆匯8月23日丨江蘇吳中(600200.SH)公佈2019年1-6月主要經營數據的公告,2019年1-6月,公司醫藥業務累計實現主營業務收入7.79億元(其中醫藥工業3.77億元,醫藥商業4.02億元),同比增長17.47%,醫藥業務主營業務毛利3.02億元,同比增長13.72%。
2019年1-6月,公司收到各類醫藥研發補貼322.58萬元。
2019年1-6月,公司醫藥研發累計投入967.34萬元,其中費用化金額712.24萬元,資本化金額255.10萬元。
2019年1-6月,公司實現房地產銷售收入5666.43萬元,較上年同期下降3108.63萬元,下降35.43%,房地產業務毛利1564.29萬元,同比增長2.73%。
至2019年6月末公司在建房地產項目總用地面積為8.75萬平方米,總建築面積為22.6萬平方米。2019年1-6月公司無新開工房地產項目。
2019年初,公司房地產項目可供出售面積為21.39萬平方米,2019年1-6月已售或預售21391.63平方米。
2019年1-6月,公司化工業務實現主營業務收入1793.98萬元,同比下降91.98%,實現主營業務毛利-172.60萬元,較上年同期下降5434.32萬元,下降103.28%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.